搜索结果: 1-15 共查到“知识库 医学 SARS-CoV-2”相关记录27条 . 查询时间(0.046 秒)
高致病性冠状病毒具有高发病率，高病死率以及全球大流行等特点，严重威胁人类健康，给社会经济带来巨大挑战。本文从高致病性冠状病毒的基因结构特点与致病机理的相关性进行综述，为预防和治疗高致病性冠状病毒感染提供参考。
新型冠状病毒肺炎患者血清SARS-CoV-2抗体的检测分析
新型冠状病毒肺炎 新型冠状病毒 免疫球蛋白M 免疫球蛋白G
2021/3/22
分析新型冠状病毒肺炎（corona virus disease 2019，COVID-19） 患者血清新型冠状病毒（severeacute respiratory syndrome coronavirus 2，SARS-CoV-2）IgM 和IgG 抗体的变化规律及临床应用。方法 收集2020 年1 ～ 2 月初温州医科大学附属乐清医院收治的28 例SARS-CoV-2 核酸检测阳性的COVID-...
评价三种新型冠状病毒（SARS-CoV-2）抗体化学发光试剂盒的检测性能，研究SARS-CoV-2 抗体检测的临床应用价值。方法 采用37 例临床确诊新型冠状病毒肺炎（COVID-19）患者恢复期血清样本和100 例对照患者血清样本，对三个不同厂家的化学发光新型冠状病毒抗体检测试剂盒进行评估。绘制ROC 曲线分析三种试剂的检测性能。利用Kappa 统计分析三种试剂的检测一致性。
选择合适的标本类型进行SARS-CoV-2检测，为新型冠状病毒肺炎（COVID-19）的早期诊断提供依据。 方法：采集咽拭子核酸检测阳性的4名COVID-19患者的鼻拭子、粪便、尿液、血液（分离血清）标本，用实时荧光RT-PCR进行SARS-CoV-2核酸检测，用化学发光法检测患者血清IgM和IgG。
A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
Preventive medicine SARS-CoV-2 Viral infection
2020/6/11
An outbreak of the coronavirus disease 2019 (COVID-19)1–3, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)4 spread globally. Countermeasures are needed to treat and prevent ...
Structural basis for RNA replication by the SARS-CoV-2 polymerase
2019-nCoV SARS-CoV-2 COVID-19 remdesivir favipiravir polymerase RdRP virus nsp12 nsp8
2020/6/11
Nucleotide analog inhibitors, including broad-spectrum remdesivir and favipiravir, have shown promise in in vitro assays and some clinical studies for COVID-19 treatment, this despite an incomplete me...
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
SARS-CoV-2 human ACE2 transgenic mouse COVID-19 pneumonia
2020/6/11
COVID-19 has spread worldwide since 2019 and is now a severe threat to public health. We previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV-2) that uses human angi...
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
Novel coronavirus alkaloid broad-spectrum antiviral 2019-nCoV SARS-CoV-2
2020/6/11
The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined...
Key Residues of the Receptor Binding Motif in the Spike Protein of SARS-CoV-2 That Interact With ACE2 and Neutralizing Antibodies
SARS-CoV-2 cross-neutralizing antibody receptor binding motif spike protein substitution mutation
2020/6/11
Coronavirus disease 2019 (COVID-19), caused by the novel human coronavirus SARS-CoV-2, is currently a major threat to public health worldwide. The viral spike protein binds the host receptor angiotens...
Structural Basis for the Inhibition of SARS-CoV-2 Main Protease by Antineoplastic Drug Carmofur
SARS-CoV-2 cross-neutralizing antibody receptor binding motif spike protein substitution mutation
2020/6/11
The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (Mpro). Here, the X-ray crystal structure of Mpro in complex with carmofur reveals that the carbonyl reactive group of...
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
The anti-influenza virus drug arbidol efficient inhibitor SARS-CoV-2 in vitro
2020/6/11
Since December 2019, a novel disease COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread to over 200 countries and infected over 1.50 million people includin...
As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and ...
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Structure-based design antiviral drug candidates targeting SARS-CoV-2 protease
2020/6/12
SARS-CoV-2 is the etiological agent responsible for the global COVID-19 outbreak. The main protease (Mpro) of SARS-CoV-2 is a key enzyme that plays a pivotal role in mediating viral replication and tr...
SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells
SARS-CoV-2-encoded nucleocapsid protein acts viral suppressor of RNA interference cells
2020/6/12
We thank Prof. Peng Zhou (Wuhan, China) for kindly providing materials and thank Yan Wu and Weijuan Shang for experimental assistance. This work was supported by the Strategic Priority Research Progra...
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Structure Mpro SARS-CoV-2 discovery inhibitors
2020/6/12
A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the aetiological agent responsible for the 2019–2020 viral pneumonia outbreak of coronavirus disease 2019 (...